Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker for Pompe Disease AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGI-CAL PROTOCOL

NCT01457443 is registered in ClinicalTrials.gov with CENTOGENE GmbH Rostock as lead sponsor.

NCT NCT01457443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01457443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker for Pompe Disease AN INTERNATIONAL, MULTICENTER, EPIDEMIOLOGI-CAL PROTOCOL
Lead sponsor
CENTOGENE GmbH Rostock
Phase
Observational
Overall status
Withdrawn
Start date
August 20, 2018
Completion date
December 31, 2021
Enrollment
0 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac diseases, cerebral aneurysm, hepato-splenomegaly, lung disease, macroglossia, muscular weakness, obstructive sleep apnoea